Zurueck zur Suche

Reporte zur Charge U034518

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

5Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
AZ 1 WA 1 OK 1 IA 1 PA 1

VAERS 2440952

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034518

mild
Staat
AZ
Alter
1,0
Geschlecht
F
Eingang
12.09.2022
Impfdatum
24.08.2022
Beginn
01.08.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site bruising Injection site nodule

Symptomtext

Bruising and nodule on right thigh developing 1 day after vaccination. Not painful to patient. No other concerns after the vaccine. Has not changed significantly in 2.5 weeks after the vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site bruising
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2526037

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034518

gering
Staat
WA
Alter
3,0
Geschlecht
M
Eingang
08.12.2022
Impfdatum
15.11.2022
Beginn
15.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product storage error

Symptomtext

no additional Ae; Nurse reported PEDVAX HIB was administered after multiple temperature excursions to a patient on Nov 15, 2022; This spontaneous report has been received from a nurse, referring to a 3-year-old male patient. The patient's medical history, concurrent conditions, concomitant medications were not provided. On 15-NOV-2022, the patient was vaccinated with an improperly stored dose of haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB) intramuscular injection, once, lot number U034518 has been verified to be a valid lot number, expiry date 18-MAR-2024 but updated to 28-MAR-2024 after internal review) (strength, anatomical location, and dose were not reported), the third dose of pneumococcal vaccine conj 13V (crm197) (PREVNAR 13) 0.5 milliliter intramuscularly on the left deltoid, batch number FM5699 (strength, frequency, and expiry date were not reported), and a dose of diphtheria vaccine toxoid (+) hepatitis B vaccine rhbsg (yeast) (+) pertussis vaccine acellular 3-component, polio vaccine inact 3v (vero) (+) tetanus vaccine toxoid (PEDIARIX) (strengths, doses, frequencies, administration routes, anatomical locations, lot numbers, and expiry dates were not reported) all the vaccines indicated as prophylaxis (product storage error). The vaccines were stored at a temperature of -0.3 ?C (Celsius) for a time frame of 21 minutes, -1.8 ?C for 23 minutes, -2.7 ?C for 24 minutes; 0.6 ?C for 19 minutes, 0.7 ?C for 6 minutes; and 1.2 ?C for 14 minutes. There was no previous temperature excursion. No additional adverse events were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2515365

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034518

gering
Staat
OK
Alter
0,4
Geschlecht
M
Eingang
23.11.2022
Impfdatum
23.11.2022
Beginn
23.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event Product administered to patient of inappropriate age

Symptomtext

Patient received a dose of Rotovirus that was not due. He had never received any vaccinations and was having to catch up. He was not eligible to receive the Rotovirus because he was over 14 weeks old. He did not have any signs and symptoms of any reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2374946

SANOFI PASTEUR · HIB (ACTHIB) · Charge U034518

gering
Staat
IA
Alter
1,3
Geschlecht
F
Eingang
20.07.2022
Impfdatum
07.07.2022
Beginn
07.07.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration No adverse event

Symptomtext

No adverse effects reported or known. Child was up to date with vaccination at the time of administration. Dtap was given 1 month too soon. HIB and Prevnar series where completed per investigative findings.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2326545

MERCK & CO. INC. · HIB (PEDVAXHIB) · Charge U034518

gering
Staat
PA
Alter
0,3
Geschlecht
U
Eingang
22.06.2022
Impfdatum
31.05.2022
Beginn
31.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product preparation issue

Symptomtext

No adverse event; PEDVAX HIB vaccine was administered when mixed with Merck diluent and administered IM; This spontaneous report has been received from a medical assistant concerning a 4-month-old patient of an unknown gender. The patient's concomitant therapies, drug reactions or allergies, medical history, and concurrent conditions were not provided. On 31-MAY-2022, the patient was vaccinated with Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) (PEDVAXHIB) administrated intramuscularly (IM) (formulation, strength, dose, vaccination scheme, and anatomical site of vaccination were not reported, lot number U034518, which has been verified to be valid, expiration date reported and validated as 28-MAR-2024), as prophylaxis. The sterile diluent (MERCK STERILE DILUENT) (lot number T025911, which has been verified to be valid, expiration date reported and validated as 08-MAR-2023) was used to reconstitute the vaccine (medication dilution) (Product preparation issue). No adverse events details were given.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product preparation issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Prophylaxis
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-